Yiming Mu
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Thyroid Cancer Diagnosis and Treatment
- Genetics top 1%
- Mesenchymal stem cell research
- Diabetes and associated disorders
Papers in
-
- Diabetes Treatment and Management 31
- Pituitary Gland Disorders and Treatments 23
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
- Diabetes Management and Research 19
- Surgery 58
- Pancreatic function and diabetes 25
- Adrenal and Paraganglionic Tumors 16
- Co-authors
- Yu Cheng (21 shared papers)Haojie Hao (17 shared papers)Jiejie Liu (16 shared papers)Weidong Han (17 shared papers)Jingtao Dou (68 shared papers)Li Zang (57 shared papers)Weijun Gu (68 shared papers)Anping Wang (41 shared papers)
- Journals
- Journal of Diabetes (18 papers)Frontiers in Endocrinology (18 papers)Diabetes Obesity and Metabolism (13 papers)Scientific Reports (7 papers)Medicine (6 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Yiming Mu
313 papers receiving 5.2k citations
Yiming Mu's Hit Papers
Peers
Comparison fields: 5 of 132
- Endocrinology, Diabetes and Metabolism 1.6k
- Genetics 585
- Nephrology 198
- Surgery 1.1k
- Physiology 429
Countries citing papers authored by Yiming Mu
This map shows the geographic impact of Yiming Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Mu more than expected).
Fields of papers citing papers by Yiming Mu
This network shows the impact of papers produced by Yiming Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Mu. The network helps show where Yiming Mu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiming Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 332 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 228 | |
| 2 | 2012 | 208 | |
| 3 | Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults Hit paper breakdown → | 2023 | 200 |
| 4 | 2013 | 197 | |
| 5 | 2015 | 128 | |
| 6 | 2019 | 120 | |
| 7 | 2003 | 116 | |
| 8 | 2016 | 99 | |
| 9 | 2017 | 93 | |
| 10 | 2017 | 93 | |
| 11 | 2013 | 90 | |
| 12 | 2023 | 88 | |
| 13 | 2020 | 83 | |
| 14 | 2018 | 81 | |
| 15 | 2014 | 74 | |
| 16 | Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial Hit paper breakdown → | 2024 | 69 |
| 17 | 2013 | 63 | |
| 18 | 2015 | 61 | |
| 19 | 2020 | 59 | |
| 20 | 2015 | 58 |
About Yiming Mu
Yiming Mu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Epidemiology and Nephrology, having authored 332 papers that have together received 5.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (31 papers), Pancreatic function and diabetes (25 papers), Pituitary Gland Disorders and Treatments (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Chronic Kidney Disease and Diabetes (19 papers), Diabetes Management and Research (19 papers), Mesenchymal stem cell research (16 papers) and Adrenal and Paraganglionic Tumors (16 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Genetics (585 citations), Nephrology (198 citations), Surgery (1.1k citations) and Physiology (429 citations). Yiming Mu has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Yu Cheng, Haojie Hao, Jiejie Liu, Weidong Han, Jingtao Dou, Li Zang, Weijun Gu, Anping Wang, Juming Lu and Kang Chen. Their work appears in journals such as Journal of Diabetes, Frontiers in Endocrinology, Diabetes Obesity and Metabolism, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.